Buyers Ask 1st Circ. For Nexium Antitrust Case Redo
Direct and indirect buyers of the heartburn medication Nexium asked a First Circuit panel for another shot at a pay-for-delay class action against AstraZeneca PLC and Ranbaxy Inc., arguing that the...To view the full article, register now.
Already a subscriber? Click here to view full article